Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

BACKGROUND: Few data are available on compliance and safety of adjuvant chemotherapy when indicated in elderly breast cancer patients; CMF (cyclophosphamide, methotrexate, fluorouracil) can be reasonably considered the most widely accepted standard of treatment. METHODS: We retrospectively reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales: De Maio, Ermelinda, Gravina, Adriano, Pacilio, Carmen, Amabile, Gerardo, Labonia, Vincenzo, Landi, Gabriella, Nuzzo, Francesco, Rossi, Emanuela, D'Aiuto, Giuseppe, Capasso, Immacolata, Rinaldo, Massimo, Morrica, Brunello, Elmo, Massimo, Di Maio, Massimo, Perrone, Francesco, de Matteis, Andrea
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079800/
https://www.ncbi.nlm.nih.gov/pubmed/15790416
http://dx.doi.org/10.1186/1471-2407-5-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079800/
https://www.ncbi.nlm.nih.gov/pubmed/15790416
http://dx.doi.org/10.1186/1471-2407-5-30

Ejemplares similares